About
Occlutech is a global specialist company founded in Germany in 2003, dedicated to developing, manufacturing, and commercializing minimally invasive cardiac devices. The company focuses on structural heart disease (SHD) devices, including occluders and interatrial shunt products, aimed at improving the quality of life for individuals with heart conditions. Their product portfolio addresses various conditions such as Atrial Septal Defects (ASD), Patent Foramen Ovale (PFO), Left Atrial Appendage (LAA) closure, and Ventricular Septal Defects (VSD). With around 300 employees, Occlutech operates globally, featuring manufacturing and R&D facilities in Germany and Türkiye, a finance and distribution hub in Helsingborg, Sweden, and clinical operations in Minneapolis, U.S. The company invests significantly in innovation, dedicating over 35% of its annual revenue to this area. Occlutech collaborates with healthcare professionals to design high-quality cardiac devices, emphasizing patient safety and clinical excellence to meet the needs of healthcare providers and improve patient outcomes worldwide.
Technologies
Keywords
Company Information
-
Employees 320
-
Founded 2003
-
Annual Revenue $31000000
-
Total Funding $21622712
Location
2 Landskronavaegen, Helsingborg, Skane County, Sweden, 252 32